Patents by Inventor Hajah Siti Fatimah Jaafar

Hajah Siti Fatimah Jaafar has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11029313
    Abstract: The invention generally features compositions and methods for the diagnosis, treatment, and monitoring of neoplasia in a subject, as well as methods of treatment selection.
    Type: Grant
    Filed: February 5, 2018
    Date of Patent: June 8, 2021
    Assignees: The General Hospital Corporation, Imperial College of Science, Technology and Medicine
    Inventors: Mark C. Poznansky, Hajah Siti Fatimah Jaafar, Dulcie V. Coleman, Pierre LeBlanc
  • Publication number: 20180172691
    Abstract: The invention generally features compositions and methods for the diagnosis, treatment, and monitoring of neoplasia in a subject, as well as methods of treatment selection.
    Type: Application
    Filed: February 5, 2018
    Publication date: June 21, 2018
    Inventors: Mark C. Poznansky, Hajah Siti Fatimah Jaafar, Dulcie V. Coleman, Pierre LeBlanc
  • Patent number: 9885720
    Abstract: The invention generally features compositions and methods for the diagnosis, treatment, and monitoring of neoplasia in a subject, as well as methods of treatment selection.
    Type: Grant
    Filed: December 8, 2015
    Date of Patent: February 6, 2018
    Assignee: The General Hospital Corporation
    Inventors: Mark C. Poznansky, Hajah Siti Fatimah Jaafar, Dulcie V. Coleman, Pierre LeBlanc
  • Publication number: 20160320396
    Abstract: The invention generally features compositions and methods for the diagnosis, treatment, and monitoring of neoplasia in a subject, as well as methods of treatment selection.
    Type: Application
    Filed: December 8, 2015
    Publication date: November 3, 2016
    Applicants: The General Hospital Corporation, Imperial College Campus
    Inventors: Mark C. POZNANSKY, Hajah Siti Fatimah JAAFAR, Dulcie V. COLEMAN, Pierre LEBLANC
  • Patent number: 9229004
    Abstract: The invention generally features compositions and methods for the diagnosis, treatment, and monitoring of neoplasia in a subject, as well as methods of treatment selection.
    Type: Grant
    Filed: September 28, 2009
    Date of Patent: January 5, 2016
    Assignees: THE GENERAL HOSPITAL CORPORATION, IMPERIAL COLLEGE LONDON
    Inventors: Mark C. Poznansky, Hajah Siti Fatimah Jaafar, Dulcie V. Coleman, Pierre Leblanc